Free Trial

Deciphera Pharmaceuticals (DCPH) SEC Filings & 10K Form

→ Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad)
Free dcph Stock Alerts
$14.65
+0.47 (+3.31%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent Deciphera Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/25/2024
3:38 PM		Deciphera Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:43 PM		Deciphera Pharmaceuticals (Filer)
Form ARS
04/25/2024
6:10 AM		Deciphera Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
3:30 PM		Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
6:10 AM		Deciphera Pharmaceuticals (Filer)
Form PRER14A
04/11/2024
6:10 AM		Deciphera Pharmaceuticals (Filer)
Form PRE 14A
02/14/2024
1:26 PM		ARMISTICE CAPITAL, LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
4:32 PM		Deciphera Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/09/2024
3:30 PM		Brightstar Associates LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
3:30 PM		Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:52 AM		Deciphera Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2024
6:11 AM		Deciphera Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2024
3:52 PM		Deciphera Pharmaceuticals (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
02/06/2024
6:10 AM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
8:45 AM		Deciphera Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:14 AM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:05 PM		Deciphera Pharmaceuticals (Subject)
Martin Daniel C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2023
6:06 AM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:11 AM		Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/05/2023
3:15 PM		Deciphera Pharmaceuticals (Issuer)
Dhanak Dashyant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2023
6:06 AM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:09 AM		Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:05 PM		Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:06 PM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details
06/21/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM		Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
7:45 AM		Deciphera Pharmaceuticals (Filer)
Form S-3ASR
05/03/2023
6:07 AM		Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:10 AM		Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:DCPH) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
They say it’s ‘unstoppable’ – How I made 43,509%
Investing Daily
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace